Recent Progress in Nutrition (ISSN 2771-9871) is an international peer-reviewed Open Access journal published quarterly online by LIDSEN Publishing Inc. This periodical is devoted to publishing high-quality papers that describe the most significant and cutting-edge research in all areas of nutritional sciences. Its aim is to provide timely, authoritative introductions to current thinking, developments and research in carefully selected topics. Also, it aims to enhance the international exchange of scientific activities in nutritional science and human health.

Recent Progress in Nutrition publishes high quality intervention and observational studies in nutrition. High quality systematic reviews and meta-analyses are also welcome as are pilot studies with preliminary data and hypotheses generating studies. Emphasis is placed on understanding the relationship between nutrition and health and of the role of dietary patterns in health and disease.

Topics contain but are not limited to:

  • Macronutrients
  • Micronutrients
  • Essential nutrients
  • Bioactive nutrients
  • Nutrient requirements
  • Nutrient sources
  • Human nutrition aspects
  • Functional foods
  • Nutraceuticals
  • Health claims
  • Public health
  • Diet-related disorders
  • Metabolic syndrome
  • Malnutrition
  • Nutritional supplements
  • Sport nutrition

It publishes a variety of article types: Original Research, Review, Communication, Opinion, Comment, Conference Report, Technical Note, Book Review, etc.

There is no restriction on paper length, provided that the text is concise and comprehensive. Authors should present their results in as much detail as possible, as reviewers are encouraged to emphasize scientific rigor and reproducibility.


Publication Speed (median values for papers published in 2023): Submission to First Decision: 6.7 weeks; Submission to Acceptance: 16.1 weeks; Acceptance to Publication: 6 days (1-2 days of FREE language polishing included)

Current Issue: 2024  Archive: 2023 2022 2021

Special Issue

Role of Diets, Vitamins, and Minerals in Cancers and Various Diseases

Submission Deadline: March 31, 2022 (Open) Submit Now

Guest Editor

Lunawati L Bennett, MS, PhD, PharmD, FACN

Professor of Pharmaceutical Sciences, Union University College of Pharmacy, Jackson, Tennessee, USA 

Website | E-Mail

Research Interests: role of antioxidants and nutraceuticals in cancer, pharmacogenomics, treatment of rare diseases, cancer genetics, leukemia, breast cancer, colorectal cancer, lung cancer, and brain cancer

About the topic

In addition to proper diets, exercise, and healthy living lifestyle, many people use dietary supplements such as vitamins, minerals, and herbal products, on a daily basis to improve their health’s or to treat their diseases.

Oxidative stress plays a significance role in pathogenesis of numerous diseases such as insulin resistance, cardiovascular disease, inflammation, neurodegenerative diseases, and cancers. Due to their highly reactive properties, imbalance production and removal of reactive oxygen species (ROS) and reactive nitrogen species (RNS) can damage various cellular components including DNA, proteins, lipids, carbohydrates and cell membranes. In addition to oxidative stress, environmental exposure, person’s immune system, alterations in epigenetics, and other factors can impact changed in genes that effect diseases’ risks and progressions.

This special issue is a collection of new knowledge and discoveries on the role of nutrition, antioxidants, and epigenetics alteration on diseases prevention or progression. Wide varieties of manuscripts from original research or review papers on the role of nutrition in prevention, treatment of certain diseases, and side effect related to deficiency or excess vitamins and minerals are going to be considered.

Manuscript Submission Information

Manuscripts should be submitted through the LIDSEN Submission System. Detailed information on manuscript preparation and submission is available in the Instructions for Authors. All submitted articles will be thoroughly refereed through a single-blind peer-review process and will be processed following the Editorial Process and Quality Control policy. Upon acceptance, the article will be immediately published in a regular issue of the journal and will be listed together on the special issue website, with a label that the article belongs to the Special Issue. LIDSEN distributes articles under the Creative Commons Attribution (CC BY 4.0) License in an open-access model. The authors own the copyright to the article, and the article can be free to access, distribute, and reuse provided that the original work is correctly cited.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). Research articles and review articles are highly invited. Authors are encouraged to send the tentative title and abstract of the planned paper to the Editorial Office ( for record. If you have any questions, please do not hesitate to contact the Editorial Office.

Welcome your submission!


Open Access Review

Ellagic Acid - A Dietary Polyphenol with Anticancer Activity that Deserves More Consideration

Received: 21 March 2023;  Published: 13 July 2023;  doi: 10.21926/rpn.2303011


Ellagic acid (EA) the principal polyphenol of pomegranate (Punicca granatum) is renowned for its beneficial therapeutic activity in several diseases including cancer. Studies have shown that EA exerts a carcinopreventive effect on many cancer cells, inducing cell cycle arrest and apoptosis, and limiting neovascularization [...]
Open Access Review

Dietary Modulation of the Gut Microbiome in Inflammatory Bowel Disease

Received: 28 April 2022;  Published: 09 August 2022;  doi: 10.21926/rpn.2203019


Inflammatory bowel disease (IBD), which includes ulcerative colitis, and Crohn’s disease, is a chronic relapsing-remitting inflammatory state of the gastrointestinal (GI) system. The cause of IBD is multifactorial, encompassing factors of genetics, environment, and the host immune system, initiating a complex interplay of maladaptive host [...]
Open Access Review

Role of Diet in the Pathogenesis of Colorectal Polyps and Cancer

Received: 24 April 2022;  Published: 01 August 2022;  doi: 10.21926/rpn.2203018


Colorectal cancer (CRC) is currently the third most common cancer within the United States among both males and females, with increasing rates occurring in younger individuals compared to the past. Multiple environmental and social aspects including diet may be contributing to this increase in CRC rates. The aim of this review [...]
Open Access Review

Nutritional Health and Bioflavonoids

Received: 23 March 2022;  Published: 21 July 2022;  doi: 10.21926/rpn.2203017


Flavonoids are phytochemicals (polyphenols) of plant origin. They can trap free oxygen radicals generated by mitochondria and other electronic transport chains, thereby inhibiting inflammatory and carcinogenic changes in vivo and in vitro. Why the body requires these compounds for the well-being of the organism and the maintenance of human [...]
Open Access Review

Sulforaphane: The Principal Broccoli Phytochemical as a Cancer Challenger

Received: 10 January 2022;  Published: 14 March 2022;  doi: 10.21926/rpn.2201008


Broccoli has long been reported to exert a positive impact on human health. It contains high levels of isocyanates, the most important of which is sulforaphane (SFN). Numerous studies have demonstrated that SFN can be used as an effective supplement for treating a variety of diseases. In addition, it is known to possess anti-cancer properties [...]
Open Access Short Communication

Gut Microbiota Potentiates the Effect of Immune Checkpoint Therapy against Cancers

Received: 16 November 2021;  Published: 08 March 2022;  doi: 10.21926/rpn.2201007


Immune checkpoints have been aggressively investigated for anti-cancer immunotherapy. The power of microbiota on the outcome of this immunotherapy has attracted much attention. For example, intestinal microorganisms play a key role in the effectiveness of programmed cell death 1 (PD1) and cytotoxic T lymphocyte-associated antigen [...]